Variable | Number (%) or median (IQR) |
---|---|
Age (years) | 39 (33–45) |
Gender | |
Female | 178 (65.7) |
Males | 93 (34.3) |
Baseline CD4 (cells/mm3) | 139.5 [IQR 60–210] |
WHO stage | |
Stage 1 | 11 (4.0) |
Stage 2 | 66 (24.1) |
Stage 3 | 131 (47.8) |
Stage 4 | 66 (24.1) |
BMI (kg/m2) | 21.9 (19.7–24.0) |
ARV regimes | |
Stavudine based | 34 (12.4) |
Zidovudine based | 129 (47.1) |
Tenofovir based | 111 (40.5) |
Adherence level (%) | |
>95 | 267 (97.4) |
<95 | 7 (2.6) |